Speakers

Andrew Clutterbuck

Merck

MSAT Director, EMEA

Andrew Clutterbuck serves as the Director of Merck’s Manufacturing Sciences & Technology (MSAT) group for the Europe, Middle East, and Africa regions. With 25 years of experience in biomanufacturing, he has a comprehensive background that spans from process development to cGMP manufacturing. Andrew joined Merck in 2011, bringing with him a wealth of expertise gained from various development and manufacturing roles at contract manufacturing organizations in the UK, where he focused on developing, scaling, and manufacturing biopharmaceuticals. He holds a degree in Molecular & Cellular Biology from the University of Huddersfield, UK.

Opportunities for Integration of Single-use, Continuous Manufacturing, & Digitalization

As the biotechnology sector seeks increased efficiency, flexibility, and sustainability, smaller batch sizes and intensified production process has emerged as a compelling solution. Manufacturers are beginning to recognize the strategic advantages of using single-use technology at smaller scales to lower production costs and enhanced overall manufacturing throughput. This shift is further fueled by a collaborative and innovation-driven mindset among manufacturers and suppliers, which fosters more streamlined production processes, with automation and advanced data analytics leading the way.

In this presentation, we will explore biotech companies can harness these innovations to facilitate the transition toward the “factory of the future” By tackling these challenges, our goal is to equip attendees with actionable strategies to enhance their operational capabilities and fully embrace the future of biotechnology.

Merck

Sparking Discovery, Elevating Humanity

In our rapidly changing and uncertain world, factors such as an aging population, chronic diseases, AI, climate change, and other megatrends have created an appetite for scientific breakthroughs that can make a positive difference across our global society. The pace of change will increase over coming decades as technologies evolve and converge in ways that fundamentally transform how we live and work. At Merck, change is not a threat but an opportunity as they have proven for over more than 350 years.

Visit the website of Merck